Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Clinical trial NCT01217944 · COMPLETED
Trial details
- NCT number
- NCT01217944
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-08-01
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.